Bacterial targeting of the P-glycoprotein/endocannabinoid axis for reducing intestinal inflammation in ulcerative colitis
细菌靶向 P-糖蛋白/内源性大麻素轴以减少溃疡性结肠炎的肠道炎症
基本信息
- 批准号:10537517
- 负责人:
- 金额:$ 3.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:ABCB1 geneAffectAgeAntibioticsAntibodiesAutomobile DrivingBacteriaBacterial InfectionsBiochemical PathwayColitisColonColonic inflammationDataDatabasesDependenceDevelopmentDiseaseDisease modelEconomicsEndocannabinoidsEnterocytesEpithelialEpithelial CellsEquilibriumFecesFinancial HardshipFunctional disorderGenesHealthHealthcare SystemsHuman MicrobiomeImmuneImmune systemIn VitroInflammationInflammatoryInflammatory Bowel DiseasesInfusion proceduresInjuryIntestinesLeadLifeMaintenanceMediatingMetabolicMetagenomicsMethodsMicrobeModelingMorbidity - disease rateMucositisMulti-Drug ResistanceMusNeutrophil InfiltrationPathway interactionsPatient-Focused OutcomesPatientsPharmaceutical PreparationsPopulationPrevalencePublishingPumpReactionRegulationRelapseResearchResearch PriorityRiskSignal TransductionSingle Nucleotide PolymorphismSpontaneous colitisStratificationSystemTNF geneTRIP10 geneTestingTissuesTreatment FailureUlcerUlcerative ColitisWorkXenograft Modelbasecommensal bacteriacommensal microbescost effectivedesigndysbiosiseconomic costexperimental studygut inflammationgut microbiotaimmune activationimprovedin vivoinhibiting antibodyinsightintestinal barrierintestinal epitheliumintestinal homeostasismathematical modelmicrobialmicrobial communitymicrobiomemicrobiotamicroorganism interactionmigrationmortalitymouse modelneutrophilnovelnovel strategiespreventresponsesexside effectstandard of caresystemic inflammatory responsetherapeutic targettranscytosis
项目摘要
Project Summary/Abstract
Ulcerative Colitis (UC) is a devastating disease characterized by recurring episodic inflammation of the colonic
mucosa that imposes a significant health and monetary burden on the developed world. Currently a significant
portion of patients with UC are treated with TNFα inhibiting antibodies. Such treatments are burdensome on the
healthcare system financially and pose the risk of significant side effects and frequently lead to the development
of anti-drug antibodies, and consequent infusion reactions, and treatment failure. Consequently, researching
novel cost effective, low risk approaches for treating ulcerative colitis should be of high priority. One approach is
to leverage the microbiome to restore and maintain a non-inflammatory state in the colon, instead of targeting
the systemic immune system. Dysbiosis is a hallmark of ulcerative colitis and leads to consequent dysregulation
of local host immune pathways such as neutrophil transmigration through the intestinal epithelium, which has
been shown to be instrumental in the initiation of mucosal inflammation in UC and its perpetuation through
disruption of the intestinal barrier. The dysbiotic microbes in the colon of patients with UC have been shown to
decrease P-glycoprotein (P-gp) expression. Under homeostatic conditions P-gp inhibits neutrophil transmigration
through maintenance of a transepithelial gradient of endocannabinoids, thereby preventing aberrant
inflammation. Thus, increases in intestinal epithelial cell (IEC) P-gp expression promises to limit inflammation in
UC by preventing neutrophil transcytosis. To this end we must understand the mechanisms by which intestinal
P-gp is regulated. While previous work has shown the microbiome dependence of intestinal P-gp expression,
the specific microbial signals and the underlying metabolic networks have not yet been explored. In this proposal
I will design an optimized microbial consortium to induce P-gp in IECs and dampen colonic inflammation in
ulcerative colitis. Additionally, I study the microbial signals and underlying microbial dynamics that induces P-gp.
In Aim 1 I will determine candidate bacterial species with the potential to regulate IEC P-gp. I will then use these
strains to design and optimize a commensal consortium to induce P-gp when transferred into mice. The use of
such a consortium as a potential bacteriotherapeutic for dampening intestinal inflammation will be studied using
murine inflammatory bowel disease models. In Aim 2 I will study the mechanisms by which microbes
communicate with each other and the host epithelium to induce P-gp. I will use a targeted and an unbiased
approach to determine the bacterial signals and metabolites that upregulate P-gp and study the interactions
between bacterial species that encourage P-gp induction on IECs. Overall, this study will provide insight into
how the human microbiome regulates neutrophil transmigration and consequently intestinal inflammation. The
design of the commensal consortium will serve as a first step in the development of a bacteriotherapeutic for
treatment of ulcerative colitis.
项目摘要/摘要
溃疡性结肠炎(UC)是一种以反复发作的结肠炎为特征的破坏性疾病
给发达国家带来巨大的健康和金钱负担的粘膜。目前是一个重要的
部分UC患者应用肿瘤坏死因子α抑制抗体治疗。这样的治疗对患者来说是负担
医疗保健系统的财务和构成重大副作用的风险,并经常导致发展
抗药物抗体,以及随后的输液反应和治疗失败。因此,研究
治疗溃疡性结肠炎的新的低风险、低成本的方法应该是重中之重。一种方法是
利用微生物群来恢复和维持结肠中的非炎症状态,而不是靶向
全身免疫系统。生物失调是溃疡性结肠炎的一个标志,并导致相应的失调。
局部宿主免疫途径,如中性粒细胞通过肠上皮迁移,这有
已被证明在UC的粘膜炎症的启动及其持久过程中起重要作用
肠道屏障的破坏。UC患者结肠中的非生物微生物已被证明
降低P-糖蛋白(P-gp)表达。动态平衡条件下P-gp抑制中性粒细胞迁移
通过维持跨上皮梯度的内源性大麻素,从而防止异常
发炎。因此,增加肠上皮细胞(IEC)P-gp的表达有望限制炎症反应。
通过阻止中性粒细胞转胞作用来治疗UC。为此,我们必须了解肠道感染的机制
P-gp是受调控的。虽然以前的工作已经表明肠道P-gp表达对微生物组的依赖,
具体的微生物信号和潜在的代谢网络尚未被探索。在本建议书中
我将设计一个优化的微生物联合体,在IECS中诱导P-gp并抑制结肠炎
溃疡性结肠炎。此外,我还研究了诱导P-gp的微生物信号和潜在的微生物动力学。
在目标1中,我将确定有可能调节IEC P-gp的候选细菌种类。然后我会用这些
设计和优化一个共生联合体,当将P-gp转移到小鼠体内时,诱导P-gp。对.的使用
这样的联合体作为一种潜在的抑制肠道炎症的细菌疗法将被研究使用
小鼠炎症性肠病模型。在目标2中,我将研究微生物
相互之间和宿主上皮细胞相互沟通,诱导P-gp。我会用有针对性的和不偏不倚的
确定上调P-gp的细菌信号和代谢产物并研究其相互作用的方法
促进IECS上P-gp诱导的细菌种类之间的差异。总体而言,这项研究将提供对
人类微生物群如何调控中性粒细胞迁移,从而导致肠道炎症。这个
共生联合体的设计将作为开发一种细菌疗法的第一步
溃疡性结肠炎的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin Fidelius Sallis其他文献
Benjamin Fidelius Sallis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 3.15万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 3.15万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 3.15万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 3.15万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 3.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 3.15万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 3.15万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 3.15万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 3.15万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 3.15万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




